- P-ISSN 2233-4203
- E-ISSN 2093-8950
- 권한신청
- P-ISSN2233-4203
- E-ISSN2093-8950
- ESCI, SCOPUS, KCI
논문 상세
Home > 논문 상세
In vitro Metabolism of Methallylescaline in Human Hepatocytes Using Liquid Chromatography-High Resolution Mass Spectrometry
Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2018, v.9 no.3, pp.86-90
https://doi.org/10.5478/MSL.2018.9.3.86
(The Catholic University of Korea)
(Yeungnam University)
(The Catholic University of Korea)
(National Forensic Service)
(National Forensic Service)
(The Catholic University of Korea)
(Yeungnam University)
(The Catholic University of Korea)
(National Forensic Service)
(National Forensic Service)
(The Catholic University of Korea)
Kim,
S.,
Kim,
J.,
Kim,
D. K.,
Lee,
J.,
인상환,
&
Lee,
H.
S.
(2018). . Mass Spectrometry Letters, 9(3), 86-90, https://doi.org/10.5478/MSL.2018.9.3.86
- 다운로드 수
- 조회수
Abstract
Methallylescaline, 2-(3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl)ethanamine, is a new psychoactive substance with potent agonist of 5-HT receptor, but there is little information on its pharmacological effect, metabolism, and tox- icity. It is necessary to characterize the metabolic profiling of methallylescaline in human hepatocytes using liquid chromatogra- phy-high resolution mass spectrometry. Methallylescaline was metabolized to three hydroxy-methallylescaline (M1-M3) and dihydroxy-methallylescaline (M4) via hydroxylation in human hepatocytes. CYP2D6, CYP2J2, CYP1A2, and CYP3A4 enzymes were responsible for the metabolism of methallylescaline. The metabolites as well as methallylescaline would be used for monitoring the abuse of methallylescaline,
- keywords
- methallylescaline, in vitro metabolism, liquid chromatography-high resolution mass spectrometry
참고문헌
1
UNODC. World Drug Report 2018. .
2
Halberstadt, A. L.. (2014). . Neuropharmacology, 77, 200-. http://dx.doi.org/10.1016/j.neuropharm.2013.08.025.
3
Halberstadt, A. L.. (2015). . Behav. Brain Res., 277, 99-. http://dx.doi.org/10.1016/j.bbr.2014.07.016.
4
5
6
EMCDDA. EMCDDA-Europol 2014 Annual Report on the implementation of Council Decision 2005/387/JHA. .
7
8
Caspar, A. T.. (2017). . J. Pharm. Biomed. Anal., 134, 158-. http://dx.doi.org/10.1016/j.jpba.2016.11.040.
9
Kim, J. H.. (2016). . J. Pharm. Biomed. Anal., 119, 50-. http://dx.doi.org/10.1016/j.jpba.2015.11.023.
10
11
공태연. (2018). Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes. Archives of Pharmacal Research, 41(7), 691-710.
12
정현욱. (2016). Comparative metabolism of honokiol in mouse, rat, dog, monkey, and human hepatocytes. Archives of Pharmacal Research, 39(4), 516-530.
13
14
15
Kanamori, T.. (2013). . J. Forensic. Sci., 58, 279-. http://dx.doi.org/10.1111/j.1556-4029.2012.02289.x.
- 투고일Submission Date
- 2018-09-07
- 수정일Revised Date
- 2018-09-28
- 게재확정일Accepted Date
- 2018-09-28
권호 내 다른 논문
- Mass Spectrometry in the Determination of Glycosylation Site and N-Glycan Structures of Human Placental Alkaline Phosphatase
- Identification Performance of Low-Molecular Compounds by Searching Tandem Mass Spectral Libraries with Simple Peak Matching
- Improved Calibration for the Analysis of Emerging Contaminants in Wastewater Using Ultra High Performance Liquid Chromatography and Time-of-Flight Mass Spectrometry
- Characterization of Molecular Composition of Bacterial Melanin Isolated from Streptomyces glaucescens Using Ultra-High-Resolution FT-ICR Mass Spectrometry
- In vitro Metabolism of Methallylescaline in Human Hepatocytes Using Liquid Chromatography-High Resolution Mass Spectrometry
- more
추천 논문
학술지 홈페이지 이용 환경은 크롬 브라우저 사용을 권장합니다.